120
Participants
Start Date
July 5, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
TAS-120
TAS-120 is an oral FGFR inhibitor
RECRUITING
CEMIC, CABA
RECRUITING
St Vincent's Hospital Sydney - The Kinghorn Cancer Centre, Sydney
RECRUITING
Alfred Health, Medical Oncology Unit, Second floor William Buckland Radiotherapy Center, Melbourne
RECRUITING
St John of God Subiaco Hospital, Subiaco
RECRUITING
CHA Bundang Medical Center, Seongnam
RECRUITING
IRCCS Humanitas Research Hospital, Rozzano
RECRUITING
Hospital General Universitario Gregorio Maranon, Madrid
RECRUITING
Clinica Universidad de Navarra, Medical Oncology Service (Mariano Ponz Sarvise), Madrid
RECRUITING
Hospital Universitario Fundación Jimenez Díaz, Madrid
RECRUITING
Hospital Universitario 12 de octubre, Madrid
RECRUITING
Clinica Universidad de Navarra, Pamplona
RECRUITING
Tampa General Hospital Cancer Institute, Tampa
RECRUITING
AOUI Verona - Ospedale Borgo Roma, Verona
RECRUITING
Policlinico S. Orsola-Malpighi, Bologna
RECRUITING
Kyungpook National University Hospital, Daegu
WITHDRAWN
Gabrail Cancer Center Research, Canton
RECRUITING
Inje University Haeundae Paik Hospital, Busan
RECRUITING
Henry Ford Health System, Detroit
WITHDRAWN
Dong-A University Hospital, Busan
RECRUITING
Gyeongsang National University Hospital, Jinju
RECRUITING
The Liver Institute at Methodist Dallas Medical Center, Dallas
RECRUITING
Texas Oncology Methodist DFW, Dallas
RECRUITING
Texas Onc Methodist (Charlton), Dallas
RECRUITING
Texas Oncology - Northeast, Denton
WITHDRAWN
Center for Oncology and Blood Disorders, Houston
RECRUITING
University of California San Diego UCSD - Moores Cancer Center, La Jolla
NOT_YET_RECRUITING
Jilin Cancer Hospital, Changchun
RECRUITING
Shanghai Gobroad Cancer Hospital China Pharmaceutical University, Shanghai
RECRUITING
Shandong University - Shandong Cancer Hospital, Jinan
RECRUITING
Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou
RECRUITING
Guangdong Provincial People's Hospitall, Guangzhou
RECRUITING
West China Hospital- Sichuan University, Chengdu
RECRUITING
The University of Hong Kong, Hong Kong Island
RECRUITING
The Chinese University of Hong Kong Prince of Wales Hospital, New Territories
RECRUITING
Texas Oncology, Abilene
RECRUITING
Hospital Britanico, Buenos Aires
RECRUITING
Sanatorio de la Mujer, Rosario
RECRUITING
Instituto do Cancer do Estado de Sao Paulo, Cerqueira César
RECRUITING
IOP - Instituto de Oncologia do Parana, Curitiba
RECRUITING
Hospital Erasto Gaertner, Curitiba
RECRUITING
Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto
RECRUITING
Fundacao Antonio Prudente - A.C.Camargo Cancer Center, São Paulo
NOT_YET_RECRUITING
Grand River Hospital - Grand River Regional Cancer Centre (GRRCC), Kitchener
NOT_YET_RECRUITING
Sunnybrook Health Sciences Center, Toronto
RECRUITING
University of Toronto, Toronto
NOT_YET_RECRUITING
McGill University Health Center, Montreal
RECRUITING
Harbin Medical University - Cancer Hospital, Harbin
RECRUITING
Tongji University Shanghai East Hospital, Shanghai
RECRUITING
Tohoku University Hospital, Sendai
RECRUITING
National Cancer Center Hospital East, Kashiwa-Shi
RECRUITING
Nagasaki University Hospital, Nagasaki
RECRUITING
Nagoya University Hospital, Nagoya
RECRUITING
Osaka Metropolitan University Hospital, Osaka-Fu
WITHDRAWN
Szpital Wojewdzki w Koszalinie im. Mikoaja Kopernika, Koszalin
WITHDRAWN
Centrum Onkologii Ziemi Lubelskiej im. w. Jana z Dukli, Lublin
RECRUITING
Europejskie Centrum Zdrowia Otwock Sp. Z.o.o., Otwock
RECRUITING
Centrum Onkologii-Instytut im. Marii Skłodowskiej - Curie, Warsaw
RECRUITING
Fundação Champalimaud, Lisbon
RECRUITING
Centro Hospitalar Lisboa Norte CHLN EPE - Hospital de Santa Maria, Lisbon
RECRUITING
Yonsei University Health System - Severance Hospital, Seoul
RECRUITING
The Catholic University of Korea, St. Mary's Hospital, Seoul
RECRUITING
Hospital Vall d'Hebron, Barcelona
RECRUITING
Institut Català d'Oncologia de l'Hospitalet de Llobregat - Hospital Duran i Reynals, Barcelona
Taiho Oncology, Inc.
INDUSTRY